Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

Abstract Background Bisphosphonate (BP) therapy has been associated with atypical femur fracture (AFF). However, the threshold of treatment duration leading to increased AFF risk is unclear. In a retrospective cohort of older women initiating BP, we compared the AFF risk associated with treatment fo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Joan C. Lo, Romain S. Neugebauer, Bruce Ettinger, Malini Chandra, Rita L. Hui, Susan M. Ott, Christopher D. Grimsrud, Monika A. Izano
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2020-12-01
Col·lecció:	BMC Musculoskeletal Disorders
Matèries:	Femur fracture Subtrochanter Femoral shaft Atypical fracture Bisphosphonates
Accés en línia:	https://doi.org/10.1186/s12891-020-03672-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!